Mark C. Chappell

1.1k total citations
13 papers, 820 citations indexed

About

Mark C. Chappell is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Mark C. Chappell has authored 13 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Mark C. Chappell's work include Renin-Angiotensin System Studies (11 papers), Hormonal Regulation and Hypertension (9 papers) and Receptor Mechanisms and Signaling (5 papers). Mark C. Chappell is often cited by papers focused on Renin-Angiotensin System Studies (11 papers), Hormonal Regulation and Hypertension (9 papers) and Receptor Mechanisms and Signaling (5 papers). Mark C. Chappell collaborates with scholars based in United States and Japan. Mark C. Chappell's co-authors include Carlos M. Ferrario, K. Bridget Brosnihan, E. Ann Tallant, Patricia E. Gallagher, Robson A.S. Santos, Lewis Joel Greene, Debra I. Diz, Jorge L. Pesquero, William R. Welches and Cheryl L. Chernicky and has published in prestigious journals such as Kidney International, Hypertension and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Mark C. Chappell

13 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark C. Chappell United States	12	634	404	279	214	126	13	820
Nancy T. Pirro United States	14	595 0.9×	405 1.0×	246 0.9×	170 0.8×	77 0.6×	21	797
Atsushi Shiota Japan	9	368 0.6×	192 0.5×	115 0.4×	95 0.4×	66 0.5×	13	546
Sanja Bosnyak Australia	10	438 0.7×	255 0.6×	305 1.1×	84 0.4×	50 0.4×	10	677
M F Gonzales France	6	399 0.6×	259 0.6×	109 0.4×	98 0.5×	48 0.4×	6	536
Duncan J. Campbell Australia	12	599 0.9×	385 1.0×	337 1.2×	97 0.5×	111 0.9×	16	950
Michael S. LaPointe United States	11	224 0.4×	163 0.4×	257 0.9×	62 0.3×	47 0.4×	14	513
Ulises Novoa Chile	11	249 0.4×	139 0.3×	178 0.6×	60 0.3×	35 0.3×	21	460
M V Raynolds United States	5	540 0.9×	271 0.7×	221 0.8×	108 0.5×	42 0.3×	6	670
Anne Riquier‐Brison United States	14	307 0.5×	272 0.7×	402 1.4×	57 0.3×	58 0.5×	21	832
Y. Goto Japan	10	278 0.4×	196 0.5×	859 3.1×	79 0.4×	60 0.5×	23	1.2k

Countries citing papers authored by Mark C. Chappell

Since Specialization

Citations

This map shows the geographic impact of Mark C. Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Chappell more than expected).

Fields of papers citing papers by Mark C. Chappell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Chappell. The network helps show where Mark C. Chappell may publish in the future.

Co-authorship network of co-authors of Mark C. Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Chappell. A scholar is included among the top collaborators of Mark C. Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Chappell. Mark C. Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chappell, Mark C.. (2012). Nonclassical Renin‐Angiotensin System and Renal Function. Comprehensive physiology. 2(4). 2733–2752. 9 indexed citations

Varagić, Jasmina, Aaron J. Trask, Jewell A. Jessup, Mark C. Chappell, & Carlos M. Ferrario. (2008). New angiotensins. Journal of Molecular Medicine. 86(6). 663–671. 51 indexed citations

Jessup, Jewell A., Aaron J. Trask, Mark C. Chappell, et al.. (2008). Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 294(6). H2614–H2618. 63 indexed citations

Gallagher, Patricia E., Mark C. Chappell, Carlos M. Ferrario, & E. Ann Tallant. (2005). Distinct roles for ANG II and ANG-(1–7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. American Journal of Physiology-Cell Physiology. 290(2). C420–C426. 155 indexed citations

Neves, Liomar A. A., et al.. (2003). Characterization of angiotensin-(1–7) receptor subtype in mesenteric arteries. Peptides. 24(3). 455–462. 28 indexed citations

Ferrario, Carlos M., Ronald D. Smith, Mark C. Chappell, et al.. (2002). Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. American Journal of Hypertension. 15(6). 557–564. 55 indexed citations

Yamada, Kazuo, et al.. (1999). Differential response of angiotensin peptides in the urine of hypertensive animals. Regulatory Peptides. 80(1-2). 57–66. 35 indexed citations

Chappell, Mark C., Debra I. Diz, Carla Yunis, & Carlos M. Ferrario. (1998). Differential actions of angiotensin-(1-7) in the kidney. Kidney International. 54. S3–S6. 44 indexed citations

Chappell, Mark C., Donald W. Jacobsen, & E. Ann Tallant. (1995). Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides. 16(4). 741–747. 43 indexed citations

10.

Chappell, Mark C., William R. Welches, K. Bridget Brosnihan, & Carlos M. Ferrario. (1992). Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate. Peptides. 13(5). 943–946. 20 indexed citations

11.

Chappell, Mark C., et al.. (1991). Evidence for an intrinsic angiotensin system in the canine pancreas. Journal of Hypertension. 9(8). 751–759. 86 indexed citations

12.

Welches, William R., Robson A.S. Santos, Mark C. Chappell, et al.. (1991). Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. Journal of Hypertension. 9(7). 631–638. 88 indexed citations

13.

Santos, Robson A.S., K. Bridget Brosnihan, Mark C. Chappell, et al.. (1988). Converting enzyme activity and angiotensin metabolism in the dog brainstem.. Hypertension. 11(2_pt_2). I153–7. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact